IL6 and Insulin resistance: Although our current study used a younger age cutoff level (50 years), it revealed a significant elevation of IL6 in aged patients with T2D, denoting the ongoing inflammatory status in such patients, with a potential IL6 effect on exacerbating insulin resistance in those patients.